1.

Which of the following has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in COVID-19 patients?

A. Sun Pharma
B. Zydus Cadila Pharmaceuticals
C. Cipla
D. Glenmark Pharmaceuticals
E. Torrent Pharmaceuticals
Answer» C. Cipla


Discussion

No Comment Found